This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ulrich F. C. Legler, MD; David J. Apple, MD
Charleston, SC

Arch Ophthalmol. 1991;109(11):1495-1496.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—We read with interest the letter by Milauskas¹ and also his reply² to the correspondence by Kershner³ and Ziemba.⁴ We congratulate Dr Milauskas for detailing his findings and for providing a notification of possible problems with silicone as an intraocular lens (IOL) biomaterial. These letters provide an alert to the ophthalmic community and the Food and Drug Administration.

We wish to communicate our experience with explanted silicone lenses that were submitted to the Center for Intraocular Lens Research (Salt Lake City, Utah, and Charleston, SC) between July 1987 and July 1991. Of a total of approximately 5000 explanted IOLs studied in our laboratory, 24 were silicone lenses, of which 11 were manufactured by STAAR Surgical Co (Monrovia, Calif) and 13 by Allergan Medical Optics (AMO; Irvine, Calif). The implant duration of these IOLs ranged from 7 days to 34 months (mean, 16 months). . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?